drugset / Trial / NCT03006562

PREvention of VENous ThromboEmbolism Following Radical Prostatectomy

NCT03006562

Phase 4 Terminated 501 enrolled Johns Hopkins University
RandomizedParallel-groupSingle-blindPrevention

Summary

The PREVENTER Trial aims to compare the use of perioperative pharmacologic prophylaxis (subcutaneous heparin) with intermittent pneumatic compression devices (IPCs) to the use of IPCs alone for the prevention of venous thromboembolism (VTE) after radical prostatectomy (RP).

Timeline

Start
2017-07-01
Primary completion
2019-11-01
Completion
2019-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 5000 iu Subcutaneous